AmCad BioMed Corp is a Taiwan-based company engaged in the research and development, production and manufacturing of advanced medical devices. The Company's products include AmCAD-UT, an ultrasonic computer-assisted thyroid detection system, AmCAD-US, an acoustic scattering tissue imaging platform, and AmCAD-UT, an ultrasonic Doppler image optimization platform. The Company mainly sells its products domestically and internationally.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-11-05	NT$14.45	-5.25%	204,694
26-11-04	NT$15.25	-3.17%	219,096
26-11-03	NT$15.75	-0.32%	360,041
26-11-02	NT$15.80	+2.60%	274,128
26-10-30	NT$15.40	-4.05%	458,130

End-of-day quote Taipei Exchange

More quotes

End-of-day quote Taipei Exchange 2026-11-05			5-day change	1st Jan Change
14.45 ^TWD	-5.25%		-9.97%	-1.70%

08-04	AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	902M 27.31M 24.33M 22.26M 20.27M 38.21M 2.58B 39.24M 267M 107M 1.37B 102M 100M 4.31B	P/E 2024	-25.5x	P/E 2025	-16.7x
Enterprise Value	542M 16.4M 14.61M 13.37M 12.17M 22.95M 1.55B 23.57M 161M 64.22M 821M 61.56M 60.24M 2.59B	EV / Sales 2024	20x	EV / Sales 2025	18.7x
Free-Float	46.82%	Yield 2024 *	-	Yield 2025	-

08-04	AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-26	AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-10	AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-10	AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-05	AmCad BioMed Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-02-27	AmCad BioMed Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-13	AmCad BioMed Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-10-31	AmCad Biomed Corporation to Establish the First Sustainability Development Committee	CI
24-10-31	AmCad BioMed Corporation Announces Change of the Financial Officer	CI
24-08-13	AmCad BioMed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-08-08	AmCad BioMed Corporation Announces Change of the Financial Officer	CI
24-08-08	AmCad BioMed Corporation Announces Change of the Accounting Officer	CI

22-08-09	AmCad BioMed : BOD approve the 2022 second quarter consolidated financial statements	PU
22-07-05	AmCad BioMed : is invited to Online Investor Conference held by KGI Securities	PU
22-06-09	AmCad BioMed : On behalf of our subsidiary Broadsound Co., we announce the major resolutions of 2022 Annual General Shareholders' Meeting.	PU
22-05-20	AmCad BioMed : The major resolutions of 2022 Annual General Shareholders' Meeting.	PU
22-02-18	AmCad BioMed : Announcing termination of private equity offering which was approved by 2021 Annual Shareholders' Meeting.	PU

AmCad BioMed Corporation Stock

Stocks

4188

TW0004188008

Advanced Medical Equipment & Technology

Valuation: AmCad BioMed Corporation

Chart: AmCad BioMed Corporation

Latest news: AmCad BioMed Corporation

Press Releases: AmCad BioMed Corporation

Quotes and Performance

Price Extremes

Managers and Directors: AmCad BioMed Corporation

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

1 day	-5.25%
1 week	-9.97%
Current month	-6.17%
1 month	+4.33%
3 months	+44.50%
6 months	+20.42%
Current year	-1.70%

1 week	14.25	16.6
1 month	12.8	18.85
Current year	9.06	18.85
1 year	9.06	18.85
3 years	9.06	37.4
5 years	9.06	37.4
10 years	9.06	37.4

Manager	Title	Age	Since
Yi Li Lee CEO	Chief Executive Officer	55	-
Chih-Yuan Huang DFI	Director of Finance/CFO	-	-
Chun Hsiang Yang CTO	Chief Tech/Sci/R&D Officer	-	2014-08-10

Director	Title	Age	Since
Cheng Chia Li CHM	Chairman	-	2011-05-05
Kuan Chih Chen BRD	Director/Board Member	-	2011-05-05
Yue Ju Lai BRD	Director/Board Member	-	2011-05-05

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMCAD BIOMED CORPORATION	-5.25%	-9.97%	-7.67%	-47.55%	27.69M
THERMO FISHER SCIENTIFIC, INC.	-4.14%	-4.55%	+19.26%	+48.86%	251B
INTUITIVE SURGICAL, INC.	-2.82%	+4.40%	-14.59%	+68.22%	162B
DANAHER CORPORATION	-3.66%	-4.49%	+6.66%	+14.39%	159B
BOSTON SCIENTIFIC CORPORATION	-2.58%	+4.57%	-54.86%	-15.02%	64.7B
EDWARDS LIFESCIENCES CORPORATION	+1.46%	+6.76%	+21.70%	+50.32%	57.97B
SIEMENS HEALTHINEERS AG	-2.34%	+2.35%	-0.88%	-7.71%	56.21B
VEEVA SYSTEMS INC.	-0.17%	-0.08%	+5.03%	+59.36%	50.21B
AGILENT TECHNOLOGIES, INC.	-3.04%	-5.17%	+17.04%	+57.57%	48.43B
WATERS CORPORATION	-3.11%	-5.62%	+21.81%	+73.93%	44.51B
Average	-2.42%	+0.09%	+1.35%	+30.24%	89.45B
Weighted average by Cap.	-2.04%	+0.20%	+3.61%	+40.46%

	2024	2025
Net sales	53.1M 1.61M 1.43M 1.31M 1.19M 2.25M 152M 2.31M 15.73M 6.29M 80.42M 6.03M 5.9M 254M	30.44M 921K 821K 751K 684K 1.29M 87.03M 1.32M 9.02M 3.61M 46.09M 3.46M 3.38M 145M
Net income	-50.58M -1.53M -1.36M -1.25M -1.14M -2.14M -145M -2.2M -14.99M -5.99M -76.59M -5.74M -5.62M -242M	-55.72M -1.69M -1.5M -1.37M -1.25M -2.36M -159M -2.42M -16.51M -6.6M -84.38M -6.33M -6.19M -266M
Net Debt	-355M -10.74M -9.57M -8.75M -7.97M -15.02M -1.01B -15.43M -105M -42.04M -537M -40.3M -39.43M -1.7B	-360M -10.91M -9.72M -8.89M -8.1M -15.26M -1.03B -15.67M -107M -42.71M -546M -40.94M -40.06M -1.72B